ANZCTR - Registration

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers

Trial registered on ANZCTR

Registration number

ACTRN12615001119583p

Ethics application status

Submitted, not yet approved

Date submitted

18/09/2015

Date registered

23/10/2015

Date last updated

23/10/2015

Type of registration

Prospectively registered

Titles & IDs

Public title

Target Temperature Management for Traumatic Brain Injury:
A Feasibility Study of Pyrexia Control

Scientific title

A feasibility study on the effect of target temperature management on patient temperature in traumatic brain injury patients.

Secondary ID [1]

Nil

Universal Trial Number (UTN)

Trial acronym

TTM-TBI-Feasibility

Linked study record

Health condition

Health condition(s) or problem(s) studied:

traumatic brain injury

Condition category

Condition code

Neurological

Other neurological disorders

Injuries and Accidents

Other injuries and accidents

Intervention/exposure

Study type

Interventional

Description of intervention(s) / exposure

1. If a patient has an initial temperature below 36.0 degrees celsius, the patient will be managed according to the preference of the treating clinician until temperature reaches 36.0 degrees celsius.
2. The intervention will be initiated when temperature reaches 36.0 degrees celsius
3. The aim is to control temperature to 36.0 degrees celsius, with the intention of avoiding any core temperature greater than or equal to 37.0 degrees celsius.
4. The minimum duration is 72 hours following randomisation or when mechanical ventilation is ceased, whichever occurs first.
5. The intervention may be maintained for as long as is clinically indicated at the discretion of the treating clinician.
6. The choice of intervention (physical cooling device) is at the discretion of the treating clinician.
7. Adherence will be monitored by recording hourly core temperature and use of physical cooling.

Intervention code [1]

Treatment: Other

Comparator / control treatment

Standard care: no specific guidelines will be provided on temperature management and treatment of pyrexia will occur according to clinical discretion.

Control group

Active

Outcomes

Primary outcome [1]

Mean temperature difference between the intervention and standard care groups.

All patients will have temperature monitored hourly using intravesical temperature (bladder catheter). In oliguric patients (defined as urine output < 0.3mls/kg/hr for greater than 4 hours) or patients with an open abdomen, core temperature will be measured with intravascular, oesophageal, nasopharyngeal or rectal temperature measurement.

Timepoint [1]

Hourly intravesical (bladder) temperature during the first 72 hours after randomisation.

Secondary outcome [1]

For patients that are receiving intracranial pressure monitoring as part of their standard clinical care, we will calculate mean intracranial pressure difference between the intervention and standard care groups.

Intracranial pressure will be monitored in this study with an intraparenchymal catheter or an external ventricular drain.

Timepoint [1]

In patients with a clinical indication for intracranial pressure monitoring, Intracranial pressure will be monitored hourly during the first 72 hours after randomisation or the end of mechanical ventilation.

Secondary outcome [2]

Duration of mechanical ventilation.

This will be determined by review of the hospital medical record.

Timepoint [2]

From randomisation to removal of the endotracheal tube and absence of re-intubation or non invasive ventilation for 24 hours after removal (survivors and non-survivors will be reported separately).

Eligibility

Key inclusion criteria

1. Age greater than or equal to 16
2. Blunt trauma with clinical diagnosis of TBI defined as:
a. Blunt head trauma
b. Glasgow Coma Scale (GCS) score less than or equal to 13 (prior to sedation)
c. Computed tomographic (CT) scan of the head consistent with traumatic brain injury
3. Invasive mechanical ventilation and predicted need for invasive mechanical ventilation beyond the next calendar day.
4. Screening and randomisation within 24 hours of injury

Minimum age

16 Years

Maximum age

No limit

Sex

Both males and females

Can healthy volunteers participate?

Key exclusion criteria

1. The treating physician intends to control temperature and/or induce hypothermia as part of the management plan
2. The treating clinician deems participation is not in the patient’s best interests
3. Drug or alcohol intoxication is likely to be the predominant cause of coma
4. Cardiac arrest at scene of injury
5. Spinal cord injury with confirmed neurological deficit
6. Pregnancy
7. Disability prior to injury, defined by a score of 4 or less as assessed by the extended Glasgow Outcome Score
8. Death is deemed to be imminent/inevitable or a treatment limitation order is in place
9. The patient has an underlying process or comorbidity making 180-day survival unlikely

Study design

Purpose of the study

Treatment

Allocation to intervention

Randomised controlled trial

Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)

Patients with an admission diagnosis that includes TBI that are admitted to the participating ICU are eligible for screening and evaluation for enrolment into the study. All screened patients will be entered into the screening log whether or not the patient is randomised into the study.

The study will include all patients admitted to a participating intensive care unit who fulfill all the inclusion criteria and for whom none of the exclusion criteria exist.

Methods used to generate the sequence in which subjects will be randomised (sequence generation)

Computer generated randomisation codes will be used, with stratification by study site and permuted blocks. Allocation concealment will be maintained by the use of sequentially numbered opaque envelopes.

Masking / blinding

Open (masking not used)

Who is / are masked / blinded?

Intervention assignment

Parallel

Other design features

Phase

Not Applicable

Type of endpoint/s

Safety/efficacy

Statistical methods / analysis

The main analyses will be conducted on an intention to treat basis using standard statistical approaches for categorical and continuous data. The difference in the 72-hour temperature curves in patients randomised to the intervention group compared to the control group will be analysed using a repeated-measure linear model with generalised estimating equations to model within-patient correlations. The model will include fixed effects of treatment and time as well as baseline temperature as covariate. The primary analysis will include all available data without imputation.

A statistical analysis plan will be agreed upon prior to entry of data into the electronic database and prior to any analyses being conducted.

Recruitment

Recruitment status

Not yet recruiting

Date of first participant enrolment

Anticipated

1/02/2016

Actual

Date of last participant enrolment

Anticipated

1/02/2017

Actual

Date of last data collection

Anticipated

Actual

Sample size

Target

Accrual to date

Final

Recruitment in Australia

Recruitment state(s)

NSW,QLD

Recruitment hospital [1]

St George Hospital - Kogarah

Recruitment hospital [2]

Liverpool Hospital - Liverpool

Recruitment hospital [3]

Royal North Shore Hospital - St Leonards

Recruitment hospital [4]

Royal Brisbane & Womens Hospital - Herston

Recruitment outside Australia

Country [1]

New Zealand

State/province [1]

Wellington

Funding & Sponsors

Funding source category [1]

Charities/Societies/Foundations

Name [1]

Intensive Care Foundation (Application in progress)

Address [1]

Level 2, 10 Ievers Terrace
Carlton, Victoria 3053, Australia

Country [1]

Australia

Primary sponsor type

Other

Name

The George Institute for Global Health

Address

The Division of Critical Care and Trauma
The George Institute for Global Health
Level 13, 321 Kent St, Sydney, NSW 2000, Australia

Country

Australia

Secondary sponsor category [1]

Hospital

Name [1]

St. George Hospital Clinical School

Address [1]

Pitney Building, 2 Chapel St, Kogarah NSW 2217

Country [1]

Australia

Ethics approval

Ethics application status

Submitted, not yet approved

Ethics committee name [1]

Royal Prince Alfred Hospital Ethics Committee

Ethics committee address [1]

Research Development Office
RPAH Medical Centre
Suite 210A, 100 Carillon Avenue
NEWTOWN NSW 2042

Ethics committee country [1]

Australia

Date submitted for ethics approval [1]

14/09/2015

Approval date [1]

Ethics approval number [1]

Summary

Brief summary

Injuries to the brain that occur after an accident, such as a car crash or after a fall, can be serious and have lasting negative consequences. Estimates suggest that at least 10 million people globally are affected by this type of brain injury every year, known as traumatic brain injury. Those that survive are often left with significant physical and or mental disabilities that are challenging to manage for the patients, their families and the health care system.

Prevention of the accidents are important, but it is also important to find treatments that can help the recovery of patients affected by traumatic brain injury. At present there are a limited number of treatments that improve the recovery of these patients. One important area that has promising evidence is temperature control. Our group has contributed to evidence in this area of study.

Preliminary evidence suggests that a raised temperature is a very common occurrence and that it may be harmful after traumatic brain injury. Yet, there still remains substantial uncertainty about this finding and whether reducing the patients temperature will help in their recovery.
In clinical practice in Australia, cooling treatments are used with substantial variability by doctors, without certainty that the treatment will help the patient recover. Additionally, From our prior research, we know that often the temperature of patients still remains above the normal range, despite the use of cooling treatments.

Therefore, we propose a study to work out if it is possible to maintain patient temperature in a targeted low normal range and avoid any elevation of temperature. From our prior work, maintaining temperature in a low normal range is an approach that is used in some centres in Australia.

If we are able to maintain temperature in a low normal range successfully, then our plan is to apply for a larger grant to work out if this approach helps with the recovery after traumatic brain injury a study that would help inform the way patients are treated. This larger type of study would require about 1000 patients, but the study that we are seeking to do now only involves 50 patients and is designed to provide practical, preliminary information to enable us to proceed to the next stage.

Trial website

N/A

Trial related presentations / publications

N/A

Public notes

N/A

Contacts

Principal investigator

Name

Dr Manoj Saxena

Address

Division of Critical Care and Trauma
The George Institute for Global Health,
Level 13, 321 Kent Street, Sydney NSW 2000.

Country

Australia

Phone

+61296570348

Fax

msaxena@georgeinstitute.org.au

Contact person for public queries

Name

Manoj Saxena

Address

Division of Critical Care and Trauma
The George Institute for Global Health,
Level 13, 321 Kent Street, Sydney NSW 2000.

Country

Australia

Phone

+61296570348

Fax

msaxena@georgeinstitute.org.au

Contact person for scientific queries

Name

Manoj Saxena

Address

Division of Critical Care and Trauma
The George Institute for Global Health,
Level 13, 321 Kent Street, Sydney NSW 2000.

Country

Australia

Phone

+61296570348

Fax

msaxena@georgeinstitute.org.au

No information has been provided regarding IPD availability

What supporting documents are/will be available?

No Supporting Document Provided

Results publications and other study-related documents

Documents added manually

No documents have been uploaded by study researchers.

Documents added automatically

Source	Title	Year of Publication	DOI
Embase	Interventions to reduce body temperature to 35 C to 37 C in adults and children with traumatic brain injury.	2020	https://dx.doi.org/10.1002/14651858.CD006811.pub4

N.B. These documents automatically identified may not have been verified by the study sponsor.

Trial Review

Registering a new trial?

Documents added manually

Documents added automatically